Thermal Burn Clinical Trial
Official title:
Single-Stage Integra Reconstruction in Burns
This is a prospective, descriptive, pilot case series involving patients with significant burns who are candidates for reconstruction with Integra®. Subjects would have a small area of the wound would, at the time of excision, have the smallest sheet of thin Integra® (125 cm2) placed and be immediately autografted with a 3:1 meshed split-thickness skin graft. Of note, 125 cm2 represents approximately 0.7% of an average sized patient's total body surface area, so for even the smallest burns in our proposed trial, this area would represent a small portion of the patient's area of injury. The remaining injury areas would be covered with standard-thickness Integra® only.
Integra®, a synthetic dermal substitute, has been utilized in burn care for decades. Typically, 10-14 days after Integra® placement, a patient returns to the operating room, the top silastic layer of the Integra® is removed, and an autograft - a split-thickness skin graft harvested from the patient - is applied directly on top of the incorporated Integra®. The result is regarded to be a cosmetically and functionally superior result to that which would have been obtained had the wound bed itself been autografted at the time of excision, as opposed to being covered by Integra® and autografted during a second operation. Integra® use in single-stage procedures to cover defects without grafting has shown benefit when defects are fairly small, e.g. fingertip injuries, and small head and neck skin cancer resections. While single-stage reconstruction with Integra® has been demonstrated with standard thickness Integra®, this decreased thickness would increase the likelihood of graft survival due to the decreased distance of nutrient diffusion. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04368117 -
STAT: Standard Therapy Plus Active Therapy
|
N/A | |
| Recruiting |
NCT06223269 -
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
|
Phase 3 | |
| Completed |
NCT05167461 -
AutoMated BUrn Diagnostic System for Healthcare (AMBUSH)
|
||
| Terminated |
NCT03148977 -
Evaluating MMPs in Burns
|
||
| Completed |
NCT02362386 -
Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System
|
N/A | |
| Completed |
NCT04073030 -
Burn Injury In a Child Due to Cyanoacrylate-Based Nail Glue- Case Report and Literature Review
|
||
| Recruiting |
NCT04138394 -
VItamin C in Thermal injuRY: The VICToRY Trial
|
Phase 3 | |
| Withdrawn |
NCT03248154 -
Biofilm Infection in Adults and Children Burn Injury
|
N/A | |
| Recruiting |
NCT05084183 -
Evaluation of the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag®
|
N/A | |
| Completed |
NCT04500314 -
Efficacy of Whole-body Vibration on Balance Control, Postural Stability and Mobility After Thermal Burn Injuries.
|
N/A | |
| Withdrawn |
NCT04684121 -
Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing
|
Phase 2 | |
| Suspended |
NCT03435172 -
Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds
|
N/A | |
| Available |
NCT04040660 -
Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
|